Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
3.980
-0.050 (-1.24%)
At close: Dec 5, 2025, 4:00 PM EST
3.980
0.00 (0.00%)
After-hours: Dec 5, 2025, 4:10 PM EST
Rapid Micro Biosystems Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Rapid Micro Biosystems stock have an average target of 8.00, which predicts a 101.01% increase from the current stock price of 3.98.
Price Target: $8.00 (+101.01%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 28, 2025.
Analyst Ratings
The average analyst rating for Rapid Micro Biosystems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +101.01% | Jul 28, 2025 |
| Keybanc | Keybanc | Buy Initiates $8 | Buy | Initiates | $8 | +101.01% | Feb 12, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $2.75 | Hold | Reiterates | $2.75 | -30.90% | Mar 7, 2023 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 16, 2022 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +101.01% | May 11, 2022 |
Financial Forecast
Revenue This Year
33.48M
from 28.05M
Increased by 19.36%
Revenue Next Year
40.67M
from 33.48M
Increased by 21.48%
EPS This Year
-1.01
from -1.08
EPS Next Year
-0.87
from -1.01
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 34.8M | 42.2M | ||||
| Avg | 33.5M | 40.7M | ||||
| Low | 31.6M | 38.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 23.9% | 26.1% | ||||
| Avg | 19.4% | 21.5% | ||||
| Low | 12.5% | 15.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.01 | -0.85 | ||||
| Avg | -1.01 | -0.87 | ||||
| Low | -1.00 | -0.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.